Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-16-026729
Filing Date
2016-11-08
Accepted
2016-11-08 12:43:48
Documents
1
Effectiveness Date
2016-11-08

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-16-026729.paper CERTNAS 294
  Scanned paper document scanned.pdf   243502
  Complete submission text file 9999999997-16-026729.txt   1626
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-37942 | Film No.: 16005139
SIC: 2834 Pharmaceutical Preparations